Injection for treating premature ovarian failure
A technology of premature ovarian failure and injection, which is applied in the field of medicine, can solve problems such as hormone imbalance and breast cancer increase, and achieve the effects of increasing secretion, improving hot flashes and hyperhidrosis, and improving menopausal symptoms
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0012] The therapeutic agents contained in each dose of the injection for treating premature ovarian failure in this embodiment are: flavonoids: 50 mg, Vitb6: 30 mg, glutathione: 1.8 g, Vit c: 8 g, amino acids: 0.4 g, pharmaceutical excipients of the present invention Choose glucose; use medical distilled water to configure a large-capacity injection of 50ml, pharmaceutical knowledge well known to those skilled in the art, pharmaceutical excipients can also be selected from fructose, lactose, ribose, arabinose, One or more combinations of mannitol, xylitol, sorbitol, low molecular dextran, calcium gluconate, calcium phosphate, sodium chloride, for the weight of the pharmaceutical excipients added, those skilled in the art can make reasonable For the selection of the volume of the configured agent, dosages in different volumes can also be made according to the requirements; for the source of flavonoids, those skilled in the art can choose different approaches according to the we...
Embodiment 2
[0014] The therapeutic agent contained in each dose of the injection of this embodiment is: Ginkgo biloba: 40ml, cerebroprotein hydrolyzate: flavonoids: 200mg, Vitb6: 10mg, glutathione: 3.2g, Vit c: 3g, amino acid: 0.8g , The pharmaceutical adjuvant of the present embodiment selects calcium gluconate and sodium chloride for use.
Embodiment 3
[0016] The therapeutic agents contained in each dose of the injection in this embodiment are: flavonoids: 50-200 mg, Vitb6: 10-30 mg, glutathione: 1.8-3.2 g, Vit c: 3-8 g, amino acids: 0.4-0.8 g; The pharmaceutical excipients of this embodiment select xylitol and sodium chloride for use.
[0017] The dose of the injection injection of the present invention is formulated with the normal adult dose, and the doctor can appropriately increase or decrease the dose of the injection according to the patient's constitution and age. curative effect. One of the cases is listed here: the dose of the injection injection of the present invention is formulated with a normal adult dose, and the doctor can appropriately increase or decrease the dose of the injection according to the patient's constitution and age. The product of the present invention has undergone many clinical trials , have achieved varying degrees of good curative effect. Here is one case: Lv, female, 42 years old, menstr...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com